Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 12Rectal Neoplasms 5Colonic Neoplasms 5Neoplasm Metastasis 2Carcinoma, Non-Small-Cell Lung 2Advanced Solid Tumors (Excluding Breast Cancer) 2Advanced Solid Tumors 2Urologic Diseases 1Stomach Neoplasms 1Sarcoma, Ewing 1Sarcoma, Alveolar Soft Part 1Sarcoma 1Renal Insufficiency 1Refractory Solid Tumors 1Pretreated Metastatic Colorectal Cancer 1Pancreatic Neoplasms 1Neuroendocrine Tumors 1Neuroectodermal Tumors, Primitive 1Neoplasms 1Liver Neoplasms 1Liver Diseases 1Kidney Neoplasms 1Kidney Diseases 1Head and Neck Neoplasms 1Gastric Adenocarcinoma 1Esophageal Neoplasms 1Carcinoma, Renal Cell 1Biliary Tract Neoplasms 1Advanced or Metastatic Solid Tumors 1Advanced Gastrointestinal Tumors 1

Interventions

Sorafenib 2veliparib 1trifluridine tipiracil drug combination 1trametinib 1rubitecan 1repotrectinib 1pevonedistat 1pembrolizumab 1ozanimod 1fisogatinib 1ficlatuzumab 1belinostat 1bavituximab 1avelumab 1Trabectedin 1Radiotherapy 1Radiosurgery 1Paclitaxel 1Oxaliplatin 1Irinotecan 1Immunotherapy 1Dexamethasone 1Carboplatin 1Azacitidine 1Axitinib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Liver Diseases × trifluridine tipiracil drug combination × Clear all
NCT02301104 2024-09-05

A Phase I Study of TAS-102 in Patients With Advanced Solid Tumors With Hepatic Impairment

Taiho Oncology, Inc.

Phase 1 Completed
24 enrolled
Gastrointestinal

Liver Diseases, Liver Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡